Abstract

French pharmaceutical company HRA Pharma has applied for FDA approval of what could be the first OTC oral contraceptive in the United States. An OTC birth control pill would increase access to contraception at a time when reproductive rights are under threat. The company filed for the Rx-to-OTC switch less than 3 weeks after the United States Supreme Court overturned Roe v Wade.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call